Dose-escalation study of rivaroxaban (BAY 59-7939) – an...

Dose-escalation study of rivaroxaban (BAY 59-7939) – an oral, direct Factor Xa inhibitor – for the prevention of venous thromboembolism in patients undergoing total hip replacement

Bengt I. Eriksson, Lars C. Borris, Ola E. Dahl, Sylvia Haas, Menno V. Huisman, Ajay K. Kakkar, Frank Misselwitz, Eva Muehlhofer, Peter Kälebo
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
120
Year:
2007
Language:
english
DOI:
10.1016/j.thromres.2006.12.025
File:
PDF, 302 KB
english, 2007
Conversion to is in progress
Conversion to is failed